vs
CF Industries（CF）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
CF Industries的季度营收约是瑞思迈的1.3倍（$1.9B vs $1.4B），瑞思迈净利率更高（27.6% vs 26.4%，领先1.2%），CF Industries同比增速更快（22.8% vs 11.0%），过去两年CF Industries的营收复合增速更高（12.8% vs 7.8%）
CF Industries Holdings Inc.是美国知名农用肥料生产及分销商，1946年成立时名为中央农民肥料公司，总部位于芝加哥郊区的伊利诺伊州诺斯布鲁克。公司主营氨、尿素、硝酸铵等肥料产品，最初为区域农业供应合作社联盟，成立56年后完成股份化改制，转为公开上市企业。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CF vs RMD — 直观对比
营收规模更大
CF
是对方的1.3倍
$1.4B
营收增速更快
CF
高出11.9%
11.0%
净利率更高
RMD
高出1.2%
26.4%
两年增速更快
CF
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.9B | $1.4B |
| 净利润 | $495.0M | $392.6M |
| 毛利率 | 40.9% | 61.8% |
| 营业利润率 | 33.0% | 34.6% |
| 净利率 | 26.4% | 27.6% |
| 营收同比 | 22.8% | 11.0% |
| 净利润同比 | 26.3% | 13.9% |
| 每股收益（稀释后） | $2.56 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CFRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.9B | $1.3B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $1.4B | $1.2B |
净利润CFRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | — | $398.7M | ||
| Q4 25 | $495.0M | $392.6M | ||
| Q3 25 | $460.0M | $348.5M | ||
| Q2 25 | $492.0M | $379.7M | ||
| Q1 25 | $351.0M | $365.0M | ||
| Q4 24 | $392.0M | $344.6M | ||
| Q3 24 | $341.0M | $311.4M |
毛利率CFRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | 40.9% | 61.8% | ||
| Q3 25 | 38.1% | 61.5% | ||
| Q2 25 | 39.9% | 60.8% | ||
| Q1 25 | 34.4% | 59.3% | ||
| Q4 24 | 34.4% | 58.6% | ||
| Q3 24 | 32.4% | 58.6% |
营业利润率CFRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | 33.0% | 34.6% | ||
| Q3 25 | 35.0% | 33.4% | ||
| Q2 25 | 34.3% | 33.7% | ||
| Q1 25 | 27.4% | 33.0% | ||
| Q4 24 | 28.9% | 32.5% | ||
| Q3 24 | 26.6% | 31.6% |
净利率CFRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | — | 27.9% | ||
| Q4 25 | 26.4% | 27.6% | ||
| Q3 25 | 27.7% | 26.1% | ||
| Q2 25 | 26.0% | 28.2% | ||
| Q1 25 | 21.1% | 28.3% | ||
| Q4 24 | 25.7% | 26.9% | ||
| Q3 24 | 24.9% | 25.4% |
每股收益（稀释后）CFRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | — | $2.74 | ||
| Q4 25 | $2.56 | $2.68 | ||
| Q3 25 | $2.19 | $2.37 | ||
| Q2 25 | $2.37 | $2.58 | ||
| Q1 25 | $1.85 | $2.48 | ||
| Q4 24 | $1.86 | $2.34 | ||
| Q3 24 | $1.55 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | $3.2B | $663.8M |
| 股东权益账面价值 | $4.8B | $6.3B |
| 总资产 | $14.1B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.66× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资CFRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M |
总债务CFRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | $3.2B | $403.9M | ||
| Q3 25 | $3.0B | $408.7M | ||
| Q2 25 | $3.0B | $658.4M | ||
| Q1 25 | $3.0B | $663.1M | ||
| Q4 24 | $3.0B | $662.9M | ||
| Q3 24 | $3.0B | $667.6M |
股东权益CFRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | $4.8B | $6.3B | ||
| Q3 25 | $4.8B | $6.1B | ||
| Q2 25 | $5.0B | $6.0B | ||
| Q1 25 | $4.8B | $5.5B | ||
| Q4 24 | $5.0B | $5.3B | ||
| Q3 24 | $5.2B | $5.2B |
总资产CFRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | $14.1B | $8.5B | ||
| Q3 25 | $14.2B | $8.3B | ||
| Q2 25 | $13.8B | $8.2B | ||
| Q1 25 | $13.3B | $7.6B | ||
| Q4 24 | $13.5B | $7.1B | ||
| Q3 24 | $13.8B | $7.2B |
负债/权益比CFRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | 0.66× | 0.06× | ||
| Q3 25 | 0.61× | 0.07× | ||
| Q2 25 | 0.60× | 0.11× | ||
| Q1 25 | 0.62× | 0.12× | ||
| Q4 24 | 0.60× | 0.13× | ||
| Q3 24 | 0.57× | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $539.0M | — |
| 自由现金流经营现金流 - 资本支出 | $313.0M | — |
| 自由现金流率自由现金流/营收 | 16.7% | — |
| 资本支出强度资本支出/营收 | 12.1% | — |
| 现金转化率经营现金流/净利润 | 1.09× | — |
| 过去12个月自由现金流最近4个季度 | $1.8B | — |
8季度趋势，按日历期对齐
经营现金流CFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $539.0M | $339.7M | ||
| Q3 25 | $1.1B | $457.3M | ||
| Q2 25 | $563.0M | $538.8M | ||
| Q1 25 | $586.0M | $578.7M | ||
| Q4 24 | $420.0M | $308.6M | ||
| Q3 24 | $931.0M | $325.5M |
自由现金流CFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $313.0M | $311.2M | ||
| Q3 25 | $717.0M | $414.4M | ||
| Q2 25 | $318.0M | $508.2M | ||
| Q1 25 | $454.0M | $557.9M | ||
| Q4 24 | $223.0M | $288.0M | ||
| Q3 24 | $792.0M | $307.7M |
自由现金流率CFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 16.7% | 21.9% | ||
| Q3 25 | 43.2% | 31.0% | ||
| Q2 25 | 16.8% | 37.7% | ||
| Q1 25 | 27.3% | 43.2% | ||
| Q4 24 | 14.6% | 22.5% | ||
| Q3 24 | 57.8% | 25.1% |
资本支出强度CFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 12.1% | 2.0% | ||
| Q3 25 | 20.9% | 3.2% | ||
| Q2 25 | 13.0% | 2.3% | ||
| Q1 25 | 7.9% | 1.6% | ||
| Q4 24 | 12.9% | 1.6% | ||
| Q3 24 | 10.1% | 1.5% |
现金转化率CFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.09× | 0.87× | ||
| Q3 25 | 2.31× | 1.31× | ||
| Q2 25 | 1.14× | 1.42× | ||
| Q1 25 | 1.67× | 1.59× | ||
| Q4 24 | 1.07× | 0.90× | ||
| Q3 24 | 2.73× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CF
| Ammonia | $591.0M | 32% |
| UAN | $493.0M | 26% |
| Urea | $372.0M | 20% |
| Other | $244.0M | 13% |
| Other Products | $147.0M | 8% |
| Ammonium Nitrate Segment | $25.0M | 1% |
RMD
暂无分部数据
